Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21647633 | 0.90 | — | — | |
| SCHEMBL2771064 | 0.86 | HSD17B1 (0.32) | TSHR | |
| SCHEMBL28696388 | 0.86 | ALDH1A1 (0.34) | — | |
| SCHEMBL2770517 | 0.85 | — | — | |
| SCHEMBL5551882 | 0.83 | CYP2C19 (0.33) | CYP2C19 | |
| SCHEMBL1255776 | 0.82 | CYP2C19 (0.32) | CYP2C19 | |
| SCHEMBL1929150 | 0.82 | CYP2C19 (0.32) | CYP2C19 | |
| SCHEMBL4882786 | 0.81 | — | — | |
| SCHEMBL27239134 | 0.81 | CYP2C19 (0.31) | CYP2C19 | |
| SCHEMBL2770707 | 0.81 | CYP2C19 (0.31) | CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1965260-B1 | Imaging member comprising asymmetric arylamine compounds and processes for making these compounds | XEROX CORP (US) | 2010-04-21 | — | — | EP | disclosed |
| EP-1965260-A1 | Asymmetric arylamine compounds and processes for making the same | Xerox Corporation (US) | 2008-09-03 | — | — | EP | disclosed |
| US-20080206662-A1 | Asymmetric arylamine compounds and processes for making the same | XEROX CORPORATION (US) | 2008-08-28 | — | — | US | disclosed |